National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 1,797 cases where Vaccine is COVID19 and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data



Case Details

This is page 6 out of 180

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 1066906 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: New York  
Vaccinated:2020-12-30
Onset:2021-02-01
   Days after vaccination:33
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Asthenia, Axonal and demyelinating polyneuropathy, COVID-19, Computerised tomogram spine, Death, Electromyogram abnormal, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging brain normal, Mental status changes, Mobility decreased, Movement disorder, Polyneuropathy, Spinal myelogram normal, Urinary tract infection
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Dementia (broad), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Infective pneumonia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-14
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations: Influenza Vaccine
Other Medications: ACETAMINOPHEN 325 MG TABLET (.) TWO TAB(S) by mouth every 6 hours prn MAXIMUM OF 3.90 GRAMS (3900MG) OF ACETAMINOPHEN PER DAY . *12 TABLETS* dx pain, ACETAMINOPHEN 325 MG TABLET (.) TWO TAB(S) by mouth two times per day (09:00, 17:00) M
Current Illness: Dementia with behavioral disturbances.
Preexisting Conditions: 1. CAD 2. Leg edema 3. BPH 4. Vascular dementia 5. MDD/behavioral disturbances 6. Sleep wake disturbance 7. Hx BCC posterior neck 8. B/L hips and right knee OA 9. Hyponatremia
Allergies: No known allergies.
Diagnostic Lab Data: See history above.
CDC Split Type:

Write-up: 92 year-old male with PMHx of vascular dementia, BPH, MDD, sleep disturbance , basal cell carcinoma of neck, osteoarthritis, BLE edema, Guillain-Barre syndrome 30 years prior, s/p COVID positive on 1/11/21 and received IV Bamlanivimab. Sent to hospital on 2/2/21 for altered mental status, generalized weakness with inability to lift bilateral UE and difficulty moving his BLE. He was treated for UTI with 7 days of Cefepime for Morganella Morganii. He was followed by neurology with MRI of the brain and CT of the spine without acute findings. Lumbar puncture unable to be obtained. He received 5 day course of IVIG for presumed Guillain-Barre . EMG showed generalized sensory motor polyneuropathy both axon loss and demyelinating type severe in degree. However, he did not recover from his GBS symptoms, was transferred back to the nursing home and died on 2/15/2021.


VAERS ID: 1067086 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Rhode Island  
Vaccinated:2021-01-27
Onset:2021-02-12
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Blood test, Fatigue, Guillain-Barre syndrome, Immunoglobulin therapy, Muscular weakness, Neurological examination, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Armour thyroid, Trazedone, QVAR inhaler, Nasonex, melatonin, multi-vitamin, turmeric, vitamin D
Current Illness: none
Preexisting Conditions: hypothyroid
Allergies: NKA
Diagnostic Lab Data: Neurological evaluation and multiple blood tests upon hospitalization 2/15.
CDC Split Type:

Write-up: Guillain-Barre Syndrome. 3-day hospitalization, IVIg infusion. Symptoms of tingling feet (started in toes and progressed to whole foot), lower leg weakness and fatigue began 16 days post vaccination. Hospitalization 4 days post symptom onset.


VAERS ID: 1074536 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Colorado  
Vaccinated:2021-02-28
Onset:2021-03-01
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6201 / 1 RA / IM

Administered by: Military       Purchased by: ?
Symptoms: Antibody test, Areflexia, Guillain-Barre syndrome, Lumbar puncture, Plasmapheresis, Sensory loss
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations: AIDP after flu vaccine (Fluzone HD; Sanofi Pasteur; Lot UJ478AA, Exp 6/30/21)
Other Medications: carvedilol 12.5 mg bid, Alprostadil IM PRN for ED, prednisone 10 mg qD, Insulin NPHY 35U qAM, dabigatran 150 mg bid, finasteride 5 mg qD, dulaglutide 1.5 mg qWeek, spironolactone 25 mg qD, Flonase daily PRN, fluconazole 150 mg, tamsulosin
Current Illness:
Preexisting Conditions: Diabetes, HTN, MDD, LE Edema, HFrEF, AFib, OSA, diabetic retinopathy
Allergies: Atorvastatin-$g memory impairment, keflex -$gRash, metoprolol-$g Rash, doxazosin-$g Hypotension
Diagnostic Lab Data: Pending results of LP and ganglioside antibody testing
CDC Split Type:

Write-up: Patient with ascending sensory deficits consistent with AIDP. No weakness or respiratory weakness but areflexic. PLEX started on 3/4. Sensory symptoms stable. Still inpatient


VAERS ID: 1075322 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2021-02-10
Onset:2021-02-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6201 / 2 RA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Paraesthesia, Vaccination site pain
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ESCITALOPRAM; CALCIUM
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021187054

Write-up: Guillain-Barre syndrome; achy arm; tingling sensation from head to toe/whole body was tingling/weird and scary on and off sensation; This is a spontaneous report from two contactable consumers (patient''s cousin and patient herself). A 68-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration in right arm on 10Feb2021 10:30 AM at a single dose for COVID-19 immunisation. Medical history included anxiety. It was reported that the patient was "physically fit. She was thin and was about 5 feet." Ongoing concomitant medications included escitalopram (reported as "generic Lexapro") for anxiety, calcium, and multivitamins. The patient previously received flu vaccine in Oct2020. She also had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262) via an unspecified route of administration in left arm on 20Jan2021 10:30 AM for COVID-19 immunization and felt a little soreness in arm and light headache the same day. Two nights later, her scalp felt on fire and had tingling sensation in her face for three weeks. A week after the first dose, her blood pressure went up to 210/101. She went to the hospital, they controlled her pressure and put her on a pressure pill 1 a day (amlodipine). She mentioned she had felt a weird sensation and noticed some spikes in her blood pressure. Her physician told her to take another 2.5 mg amlodipine if needed. After her second dose, she went to sleep with achy arm. she woke up that night with a tingling sensation from head to toe. Her whole body was tingling. It was a weird and scary on and off sensation. She stated it had improved during the past two days. The patient confirmed that she had no heart rate problems. She actually experienced high blood pressure instead. She never had numbness, instead she had a tingling sensation still present. She mentioned her 97-year-old mother and husband both got the two doses with no complication or reactions. The patient''s cousin was "pretty sure that it''s Guillain-Barre." The patient stated the Guillain-Barre syndrome has not yet been confirmed. She had an appointment with a neurologist. The outcome of ''tingling sensation from head to toe/whole body was tingling/weird and scary on and off sensation'' was recovering, of remaining events was unknown.


VAERS ID: 1077790 (history)  
Form: Version 2.0  
Age: 42.0  
Sex: Female  
Location: Maryland  
Vaccinated:2021-02-11
Onset:2021-02-17
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-03-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Areflexia, Electromyogram, Guillain-Barre syndrome, Immunoglobulin therapy, Laboratory test, Lumbar puncture, Muscular weakness, Nerve conduction studies, Paraesthesia, Sensory disturbance
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None, prior hypertension
Allergies: None
Diagnostic Lab Data: Lumbar Puncture (3/4) Laboratory Diagnostics (3/1-3/6) EMG/NCS (3/5)
CDC Split Type:

Write-up: Guillain-Barre-Landry Syndrome (AIDP). Presented with paresthesia''s, loss of Deep Tendon Reflexes, and proximal $g distal LE weakness. Placed on IVIG on 3/4/2021 with improved symptoms of LE weakness but noted residual abnormal sensation


VAERS ID: 1077793 (history)  
Form: Version 2.0  
Age: 42.0  
Sex: Female  
Location: Hawaii  
Vaccinated:2021-01-12
Onset:2021-01-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Guillain-Barre syndrome, Heart rate abnormal, Hypoaesthesia, Paraesthesia
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Medical tests did not show evidence of this.
CDC Split Type:

Write-up: Guillain Barre Syndrome that lasted for 4 weeks. Prickling, pins and needles sensations in arm, fingers, leg, feet numbness/loss of feeling in arm and hand for weeks Difficulty with facial movements, including speaking, chewing or swallowing Severe pain, achy, shooting or cramplike Rapid heart rate Difficulty breathing


VAERS ID: 1078081 (history)  
Form: Version 2.0  
Age: 78.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-02-05
Onset:2021-03-06
   Days after vaccination:29
Submitted: 0000-00-00
Entered: 2021-03-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3427 / 1 OT / IM

Administered by: Private       Purchased by: ?
Symptoms: Diplopia, Fine motor skill dysfunction, Gait disturbance, Guillain-Barre syndrome, Lumbar puncture, Speech disorder
SMQs:, Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Ocular motility disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: benazapril dystolic hydralazine pantoprazole atorvastin calcium furosemide spririva multiple vitamin calcium, D & magnesium vitamin c vitamin e Glucosamine hci Condroitin Sulfate omega 3 fish oil CoQ-10 Aspirin Metamucil
Current Illness: high blood pressure that is treated, that is monitored
Preexisting Conditions: same as above
Allergies: sulfa gives a gastric reaction
Diagnostic Lab Data: 2/25/21: lumbar puncture
CDC Split Type:

Write-up: Guillian Barre reaction (difficulty walking, difficultyusing hands- small motor skills; difficulty speaking; began on 2/7/21 and continued to worsen until hospitalization on 2/24/21 and 5 plasmapheresis treatments. While hospitalized patient has developed double vision.


VAERS ID: 1078295 (history)  
Form: Version 2.0  
Age: 24.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-03-06
Onset:2021-03-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / UNK - / IM

Administered by: Other       Purchased by: ?
Symptoms: Condition aggravated, Guillain-Barre syndrome, Livedo reticularis, Musculoskeletal stiffness
SMQs:, Peripheral neuropathy (narrow), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Arthritis (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Hx of Guillain-Barr? like symptoms in the past
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Hx Guillain-Barr? 5-10 minutes after vaccination had mottled appearance of hands and muscle stiffness of neck, no CP or SOB, given IM benadryl and sent to ED 911 for observation


VAERS ID: 1079864 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Male  
Location: California  
Vaccinated:2021-02-23
Onset:2021-03-04
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6203 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: CSF protein increased, Dyspnoea, Guillain-Barre syndrome, Magnetic resonance imaging normal, Musculoskeletal disorder, Respiratory failure
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Cardiomyopathy (broad), Demyelination (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Hypokalaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None.
Current Illness: Recovering from Guillain-Barre Syndrome triggered by COVID December 2020. Was ambulatory again at the time of vaccination.
Preexisting Conditions: h/o CAD. s/p CABG x 5 10 years ago.
Allergies: Abalone.
Diagnostic Lab Data: increased protein in CSF. No changes on MRI.
CDC Split Type:

Write-up: 9 days after receiving vaccine, pt developed rapid onset of ascending paralysis. No use of legs, minimal use of right arm. Limited use of left arm. Repiratory difficulty/failure.


VAERS ID: 1080751 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-02-24
Onset:2021-02-25
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 043L20A / 2 RA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Acute motor-sensory axonal neuropathy, Back pain, Chest pain, Gait inability, Guillain-Barre syndrome, Hypertension, Hypoaesthesia, Musculoskeletal disorder, Nausea, Vomiting
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Dystonia (broad), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypertension (narrow), Cardiomyopathy (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Amoxicillin 875mg; Hydrochlorothiazide 25mg; Hydrocodone 7.5mg; Letrozole 2.5mg; Losartan Potassium 50mg; Potassium Chloride 20 Meq; Raloxifene Hcl 60mg; Tizanidine Hcl 4mg All daily except hydrocodone and tizanidine
Current Illness: Bronchitis
Preexisting Conditions: High Blood Pressure; Breast Cancer Survivor
Allergies: Unknown at this time
Diagnostic Lab Data: Acute Sensory Axonal Neuropathy a severe/rare case of Guillain-Barre Syndrome.
CDC Split Type:

Write-up: High blood pressure; chest pain; back pain; numbness in limbs; nausea and vomiting.; inability to walk or move legs and feet. Was officially diagnosed on 2/5/2021 wit Acute Sensory Axonal Neuropathy a severe/rare case of Guillain-Barre Syndrome. Unknown time for recovery. Is in the process of being referred to a rehab center.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166